Event
Sidley Lawyer Michael Borden To Speak on “The Biosecure Act: What Chinese Biotech and Life Sciences Companies Need To Know” Webinar
Thursday, December 18, 2025
Tune in as Sidley partner Michael Borden joins BioSeedin’s upcoming webinar, “The BIOSECURE Act: What Chinese Biotech and Life Sciences Companies Need to Know”. The session will explore the scope of the prohibitions, how Chinese firms are designated under the new law, and steps to minimize exposure (more on the Act’s inclusion in the FY26 National Defense Authorization here). Bioseedin is a leading advisory firm for biotech and pharmaceutical companies in the Asia Pacific region.
得意分野
Suggested News & Insights
Dino LaVerghetta Appointed Public Member of the Administrative Conference of the United StatesJune 17, 2026BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Singapore Cocktails and ConversationThursday, November 20, 2025The New $100,000 H-1B Fee: Immediate Impact and Long-Term Workforce Planning for U.S. EmployersWednesday, November 5, 2025Sidley Secures Major Victory for Equinor Lifting BOEM Stop-Work OrderAugust 4, 2025Supreme Court Substantially Limits Universal Injunctions (Trump v. CASA): Implications for Litigation Against the GovernmentJuly 1, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory